Farms.com Home   News

USDA Awards Additional Millions to Build Agriculture Exports

By Lindsay Croke

This week, the U.S. Grains Council received notice of additional funding from the U.S. Department of Agriculture under its Regional Agriculture Promotion Program (RAPP). The award will disperse $17 million to USGC for use in developing markets that will build U.S. agriculture exports.

“The U.S. Grains Council is IL Corn’s most important partner when we think about growing international markets for corn and corn products like ethanol,” said Mark Wilson, USGC Secretary-Treasurer and farmer from Toulon. “This additional funding from the USDA will bolster the Council’s ability to build relationships and capitalize on opportunities to bring U.S. agricultural products to new areas that show potential for export growth.”

RAPP was launched after a request from the U.S. Senate Committee on Agriculture, Nutrition, and Forestry to bolster, diversify, and expand market opportunities for U.S. agriculture products. This round of funding is the first of five tranches, with the next coming in 2026.

The majority of the Council’s RAPP funding will be used to enhance its programming in Africa, Latin America, the Middle East, South and Southeast Asia, where rapid population and economic growth is creating demand for high-quality agriculture products that the U.S. industry will be positioned to meet.

Other portions of the investment will be committed to solidifying U.S. producers’ stances in existing top export markets and to add staff in the Council’s Washington, D.C. headquarters to properly manage and administer the Council’s higher international activity.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.